‘The Gruber Moment’: How CBER Got The Answers It Wanted On COVID Vaccine Guidance

 
• By Kate Rawson
US FDA's CBER's Office of Vaccine Research & Review Director Marion Gruber presents during the 22 October VRBPAC meeting.
CBER's Office of Vaccine Research & Review Director Marion Gruber presents during the 22 October VRBPAC meeting. • Source: screenshot

More from US FDA Performance Tracker

More from Regulatory Trackers